These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3379566)

  • 1. Renal tubular mechanisms for excretion of cefpiramide (SM-1652) in association with its long-lasting pharmacokinetic properties.
    Matsui H; Okuda T
    J Pharmacobiodyn; 1988 Feb; 11(2):67-73. PubMed ID: 3379566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: renal clearance in rats and rabbits.
    Yamazaki I; Shirakawa Y; Fugono T
    J Antibiot (Tokyo); 1981 Aug; 34(8):1055-63. PubMed ID: 6274837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of cefpiramide and cefazolin into peritoneal capsular fluid in rabbits.
    Matsui H; Okuda T
    Antimicrob Agents Chemother; 1988 Jan; 32(1):33-6. PubMed ID: 3348610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: effect of para-aminohippurate on renal clearance and intrarenal distribution of cephalosporins in rabbits.
    Yamazaki I; Shirakawa Y; Fugono T
    J Antibiot (Tokyo); 1981 Nov; 34(11):1476-85. PubMed ID: 6274834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans.
    Lee FH; Pfeffer M; Van Harken DR; Smyth RD; Hottendorf GH
    Antimicrob Agents Chemother; 1980 Feb; 17(2):188-92. PubMed ID: 7387141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics and safety of high doses of ceforanide (BL-S786R) and cefazolin.
    Smyth RD; Pfeffer M; Glick A; Van Harken DR; Hottendorf GH
    Antimicrob Agents Chemother; 1979 Nov; 16(5):615-21. PubMed ID: 526003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefpiramide kinetics and plasma protein binding in cholestasis.
    Demontes-Mainard F; Vinçon G; Labat L; Amouretti M; Necciari J; Kieffer G; Bannwarth B
    Br J Clin Pharmacol; 1994 Mar; 37(3):295-7. PubMed ID: 8198940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective renal tubular secretion of carbenicillin.
    Itoh T; Ishida M; Onuki Y; Tsuda Y; Shimada H; Yamada H
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2327-32. PubMed ID: 8285614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in pharmacokinetics and protein binding behavior of cefazolin in endotoxemic rats.
    Nadai M; Hasegawa T; Kato K; Wang L; Nabeshima T; Kato N
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1781-5. PubMed ID: 8239584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein binding of cefpiramide in the plasma of various species.
    Ohshima T; Hasegawa T; Johno I; Kitazawa S
    J Pharm Pharmacol; 1991 Nov; 43(11):805-6. PubMed ID: 1686912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal excretion of cephapirin and cephaloridine: evidence for saturable tubular reabsorption.
    Arvidsson A; Borgå O; Alván G
    Clin Pharmacol Ther; 1979 Jun; 25(6):870-6. PubMed ID: 445952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and saturable renal tubular secretion of zidovudine in rats.
    Patel BA; Chu CK; Boudinot FD
    J Pharm Sci; 1989 Jul; 78(7):530-4. PubMed ID: 2778651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefpiramide in rats acutely intoxicated with carbon tetrachloride.
    Li C; Nakayama S; Kurosaki Y; Nakayama T; Kimura T
    J Pharmacobiodyn; 1990 Mar; 13(3):186-94. PubMed ID: 2374088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of benzylpenicillin, cefpiramide and cefazolin by freshly prepared rat hepatocytes. Evidence for a carrier-mediated transport system.
    Tsuji A; Terasaki T; Takanosu K; Tamai I; Nakashima E
    Biochem Pharmacol; 1986 Jan; 35(2):151-8. PubMed ID: 3080003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and protein binding of cefpiramide in patients with alcoholic cirrhosis.
    Demotes-Mainard F; Vinçon G; Amouretti M; Dumas F; Necciari J; Kieffer G; Begaud B
    Clin Pharmacol Ther; 1991 Mar; 49(3):263-9. PubMed ID: 2007321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic studies on drug disposition in rabbits. I. Renal excretion of iodopyracet and sulfamethizole.
    Katayama K; Ohtani H; Kawabe T; Mizuno H; Endoh M; Kakemi M; Koizumi T
    J Pharmacobiodyn; 1990 Feb; 13(2):97-107. PubMed ID: 2384854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental and clinical evaluation of the biliary pharmacokinetic profile of cefpiramide, a new cephalosporin with high hepatic elimination.
    Brogard JM; Jehl F; Blickle JF; Arnaud JP; Monteil H
    Drugs Exp Clin Res; 1988; 14(8):519-27. PubMed ID: 3248507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cefpiramide in rats with obstructive jaundice.
    Kimura T; Yamao T; Nakayama S; Honge S; Kawakami T; Kurosaki Y; Nakayama T
    J Pharmacobiodyn; 1988 Dec; 11(12):839-48. PubMed ID: 3254982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diabetes on disposition and renal handling of cefazolin in rats.
    Nadai M; Yoshizumi H; Kuzuya T; Hasegawa T; Johno I; Kitazawa S
    Drug Metab Dispos; 1990; 18(5):565-70. PubMed ID: 1981703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney transport of cefazolin in normal and impaired renal function.
    Brodwall EK; Bergan T; Orjavik O
    J Antimicrob Chemother; 1977 Nov; 3(6):585-92. PubMed ID: 599121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.